【論文】

1.

Wakasugi M, Narita I, Iseki K, Asahi K, Yamagata K, Fujimoto S, Moriyama T, Konta T, Tsuruya
K, Kasahara M, Shibagaki Y, Kondo M, Watanabe T; Japan Specific Health Checkups (J-SHC)
Study Group. Healthy Lifestyle and Incident Hypertension and Diabetes in Participants withand without Chronic Kidney Disease: The Japan Specific Health Checkups (J-SHC) Study.
Intern Med. 2022 Mar 5. doi: 10.2169/internalmedicine.8992-21.

2.

Kosugi T, Eriguchi M, Yoshida H, Tasaki H, Fukata F, Nishimoto M, Matsui M, Samejima KI,
Iseki K, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita I, Kasahara M, Shibagaki Y,
Kondo M, Asahi K, Watanabe T, Tsuruya K; Japan Specific Health Checkups (J-SHC) Study
Group. Association between chronic kidney disease and new-onset dyslipidemia: The Japan
Specific Health Checkups (J-SHC) study. Atherosclerosis. 2021 Sep;332:24-32. doi:
10.1016/j.atherosclerosis.2021.08.004. Epub 2021 Aug 4.

3.

Hibino M, Otaki Y, Kobeissi E, Pan H, Hibino H, Taddese H, Majeed A, Verma S, Konta T,
Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T,
Kondo M, Asahi K, Watanabe T, Watanabe T, Watanabe M, Aune D.

Blood Pressure,

Hypertension, and the Risk of Aortic Dissection Incidence and Mortality: Results From the JSCH Study, the UK Biobank Study, and a Meta-Analysis of Cohort Studies. Circulation. 2022
Mar;145(9):633-644. doi: 10.1161/CIRCULATIONAHA.121.056546. Epub 2021 Nov 8.
4.

Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki
Y, Moriyama T, Kondo M, Watanabe T. Higher cardiovascular mortality in men with persistent
dipstick hematuria. Clin Exp Nephrol. 2021 Feb;25(2):150-156. doi: 10.1007/s10157-02001971-z. Epub 2020 Sep 22.

5.

Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K,
Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T. Impact ofChronic Kidney Disease on Aortic Disease-related Mortality: A Four-year Community-Based
Cohort Study. Intern Med. 2021;60(5):689-697. doi: 10.2169/internalmedicine.5798-20. Epub
2021 Mar 1.

6.

Matsui M, Tsuruya K, Yoshida H, Iseki K, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita
I, Kasahara M, Shibagaki Y, Kondo M, Asahi K, Watanabe T. Trace proteinuria as a risk factor
for cancer death in a general population.

Sci Rep. 2021 Aug 19;11(1):16890. doi:10.1038/s41598-021-96388-3.
7.

Araumi A, Ichikawa K, Konta T, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K,
Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T. The distribution of eGFR
by age in a community-based healthy population: the Japan specific health checkups study(J-SHC study). Clin Exp Nephrol. 2021 Dec;25(12):1303-1310. doi: 10.1007/s10157-02102107-7. Epub 2021 Jul 3.

8.

Otaki Y, Konta T, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita
I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, Watanabe T.

Possible burden of

hyperuricaemia on mortality in a community-based population: a large-scale cohort study. Sci
Rep. 2021 Apr 26;11(1):8999. doi: 10.1038/s41598-021-88631-8.
9.

Iwasaki M, Kudo A, Asahi K, Machii N, Iseki K, Satoh H, Moriyama T, Yamagata K, Tsuruya K,
Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro
M. Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohortfrom a Japanese general population. Sci Rep. 2021 Jan 12;11(1):716. doi: 10.1038/s41598020-80572-y.

10. Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K,
Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T. One-yearchange in plasma volume and mortality in the Japanese general population: An observational
cohort study. PLoS One. 2021 Jul 13;16(7):e0254665. doi: 10.1371/journal.pone.0254665.
eCollection 2021.
11. Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M,
Kasahara M, Shibagaki Y, Asahi K, Watanabe T. Weight loss reduces the incidence of dipstick
proteinuria: a cohort study from the Japanese general population. Clin Exp Nephrol. 2021
Dec;25(12):1329-1335. doi: 10.1007/s10157-021-02114-8. Epub 2021 Jul 17.
12. Nishimoto M, Murashima M, Yoshida H, Eriguchi M, Tasaki H, Fukata F, Kosugi T, Matsui M,
Samejima KI, Iseki K, Asahi K, Yamagata K, Fujimoto S, Konta T, Narita I, Moriyama T, Kasahara
M, Shibagaki Y, Kondo M, Watanabe T, Tsuruya K; Japan Specific Health Checkups (J-SHC)
Study Group. Impact of self-reported walking habit on slower decline in renal function among
the general population in a longitudinal study: the Japan Specific Health Checkups (J-SHC)
Study. J Nephrol. 2021 Dec;34(6):1845-1853. doi: 10.1007/s40620-021-01041-x. Epub 2021

Apr 30.
13. Otaki Y, Watanabe T, Konta T, Watanabe M, Fujimoto S, Sato Y, Asahi K, Yamagata K, Tsuruya
K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T. One-Year
Change in Diastolic Blood Pressure and Aortic Disease-Related Mortality in a Japanese
General Population Aged 50-75 Years. Circ J. 2021 Nov 25;85(12):2222-2231. doi:
10.1253/circj.CJ-21-0514. Epub 2021 Sep 3.
14. Wakasugi M, Narita I, Iseki K, Asahi K, Yamagata K, Fujimoto S, Moriyama T, Konta T, Tsuruya
K, Kasahara M, Shibagaki Y, Kondo M, Watanabe T. The Effect of CKD on Associations
between Lifestyle Factors and All-cause, Cancer, and Cardiovascular Mortality: A Populationbased

CohortStudy.

Intern

Med.

2021

Jul

15;60(14):2189-2200.

doi:

10.2169/internalmedicine.6531-20. Epub 2021 Feb 15.
15. Hatano Y, Yano Y, Fujimoto S, Sato Y, Iseki K, Konta T, Moriyama T, Yamagata K, Tsuruya K,
Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T. The Population-Attributable
Fraction for Premature Mortality Due to Cardiovascular Disease Associated With Stage 1 and
2 Hypertension Among Japanese. Am J Hypertens. 2021 Feb 18;34(1):56-63. doi:
10.1093/ajh/hpaa128.
16. Ozawa S, Matsubayashi M, Nanaura H, Yanagita M, Mori K, Asanuma K, Kajiwara N, Hayashi
K, Ohashi H, Kasahara M, Yokoi H, Kataoka H, Mori E, Nakagawa T. Proteolytic cleavage of
Podocin by Matriptase exacerbates podocyte injury. J Biol Chem. 2020 Nov 20;295(47):1600216012. doi: 10.1074/jbc.RA120.013721. Epub 2020 Sep 9.
17. Fuseya S, Suzuki R, Okada R, Hagiwara K, Sato T, Narimatsu H, Yokoi H, Kasahara M, Usui T,
Morito N, Yamagata K, Kudo T, Takahashi S.

Mice lacking core 1-derived O-glycan in

podocytes develop transient proteinuria, resulting in focal segmental glomerulosclerosis.
Biochem Biophys Res Commun Ishii A, Katsuura G, Imamaki H, Kimura H, Mori KP, KuwabaraT,. 2020 Mar 19;523(4):1007-1013. doi: 10.1016/j.bbrc.2020.01.033. Epub 2020 Jan 20.
18. Ikeda T, Inoue S, Konta T, Murakami M, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya
K, Narita I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, Watanabe T. Can Daily Walking Alone
Reduce Pneumonia-Related Mortality among Older People? Sci Rep. 2020 May 22;10(1):8556.
doi: 10.1038/s41598-020-65440-z.

19. Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki
Y, Moriyama T, Kondo M, Iseki C, Watanabe T. Impact of Metabolic Syndrome on the Mortality
Rate among Participants in a Specific Health Check and Guidance Program in Japan. Intern
Med. 2020 Nov 1;59(21):2671-2678. doi: 10.2169/internalmedicine.4975-20. Epub 2020 Jul 14.
20. Kasahara M, Kuwabara Y, Moriyama T, Tanabe K, Satoh-Asahara N, Katsuya T, Hiramitsu S,
Shimada H, Sato T, Saito Y, Nakagawa T.
Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized
controlled trial. Clin Exp Nephrol. 2020 Mar;24(3):235-241.
21. Sato Y, Fujimoto S, Iseki K, Konta T, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M,
Kasahara M, Shibagaki Y, Asahi K, Watanabe T. Higher baseline uric acid concentration isassociated with non-attainment of optimal blood pressure. PLoS One. 2020 Jul
27;15(7):e0236602. doi: 10.1371/journal.pone.0236602. eCollection 2020.
22. Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K,
Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T. Impact ofhyperuricemia on mortality related to aortic diseases: a 3.8-year nationwide communitybased cohort study. Sci Rep. 2020 Aug 31;10(1):14281. doi: 10.1038/s41598-020-71301-6.
23. Konta T, Ichikawa K, Kawasaki R, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K,
Narita I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, Watanabe T.
Association between serum uric acid levels and mortality: a nationwide community-based
cohort study. Sci Rep. 2020 Apr 8;10(1):6066.
24. Usui T, Morito N, Shawki HH, Sato Y, Tsukaguchi H, Hamada M, Jeon H, Yadav MK, Kuno A,
Tsunakawa Y, Okada R, Ojima T, Kanai M, Asano K, Imamura Y, Koshida R, Yoh K, Usui J,
Yokoi H, Kasahara M, Yoshimura A, Muratani M, Kudo T, Oishi H, Yamagata K, Takahashi S.
Transcription factor MafB in podocytes protects against the development of focal
segmental glomerulosclerosis. Kidney Int. 2020 Aug;98(2):391-403. doi:
10.1016/j.kint.2020.02.038. Epub 2020 Apr 28.
25. Kuwabara Y, Yasuno S, Kasahara M, Ueshima K, Nakao K.
The association between uric acid levels and renal function of CKD patients withhyperlipidemia: a sub-analysis of the ASUCA trial. Clin Exp Nephrol. 2020 May;24(5):420426.

26. Son C, Kasahara M, Tanaka T, Satoh-Asahara N, Kusakabe T, Nishimura K, Miyamoto Y,
Kasama S, Hosoda K.
Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin
Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE
study): Protocol for a Randomized, Parallel-Group Comparison Trial. Diabetes Ther. 2020
Jan;11(1):347-358.
27. Suzuki S, Ito Y, Kasama S, Murata T, Matsuhisa M, Kasahara M.
Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic.
Diabetol Int. 2020 Jun 19;11(3):240-241.
28. Kasama S, Toyama T, Suzuki S, Ito Y, Matsumoto N, Kurabayashi M, Kasahara M.
Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity andcardiac events in patients with ischemic cardiomyopathy and mild to moderate heart failure.
Nucl Med Commun. 2019 Feb;40(2):159-168.
29. Uchida D, Kido R, Kawarazaki H, Murasawa M, Ando A, Fujimoto S, Iseki K, Moriyama T,
Yamagata K, Tsuruya K, Konta T, Narita I, Kondo M, Kasahara M, Asahi K, Watanabe T,
Shibagaki Y.

Lower Diastolic Blood Pressure was Associated with Higher Incidence ofChronic Kidney Disease in the General Population Only in those Using Antihypertensive
Medications.

Kidney Blood Press Res. 2019;44(5):973-983.

30. Takahashi S, Kasama S, Toyama T, Suzuki S, Ito Y, Nakata T, Kasahara M, Kurabayashi M.
Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity after
reperfusion therapy in patients with first ST-segment elevation myocardial infarction andnormal low-density lipoprotein cholesterol. J Nucl Cardiol. 2019 Aug 22.
31. Hirai H, Asahi K, Yamaguchi S, Mori H, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya
K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T,
Shimabukuro M. New risk prediction model of coronary heart disease in participants withand without diabetes: Assessments of the Framingham risk and Suita scores in 3-year
longitudinal database in a Japanese population. Sci Rep. 2019 Feb 26;9(1):2813. doi:
10.1038/s41598-019-39049-w.
32. Nishimoto M, Tagawa M, Matsui M, Eriguchi M, Samejima KI, Iseki K, Iseki C, Asahi K,

Yamagata K, Konta T, Fujimoto S, Narita I, Kasahara M, Shibagaki Y, Moriyama T, Kondo M,
Watanabe T, Tsuruya K.
A Prediction Model with Lifestyle in Addition to Previously Known Risk Factors Improves Its
Predictive Ability for Cardiovascular Death. Sci Rep. 2019 Sep 10;9(1):12953.
33. Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo
M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.
Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic
kidney disease diagnosed based on the presence of proteinuria and renal function: A large
longitudinal study in Japan. PLoS One. 2019 Dec 4;14(12):e0225812.
34. Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo
M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.
Cause-specific mortality in the general population with transient dipstick-proteinuria. PLoS
One. 2019 Oct 2;14(10):e0223005.
35. Kudo A, Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I,
Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M.
Fast eating is a strong risk factor for new-onset diabetes among the Japanese general
population. Sci Rep. 2019 Jun 3;9(1):8210. doi: 10.1038/s41598-019-44477-9.
36. Kon S, Konta T, Ichikawa K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara
M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T. Association between renal
function and cardiovascular and all-cause mortality in the community-based elderly
population: results from the Specific Health Check and Guidance Program in Japan. Clin Exp
Nephrol. 2018;22(2):346-352.
37. Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M,
Kasahara M, Shibagaki Y, Asahi K, Watanabe T. Anemia as a risk factor for all-cause
mortality: obscure synergic effect of chronic kidney disease. Clin Exp Nephrol.
2018;22(2):388-394.
38. Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M,
Shibagaki Y, Moriyama T, Kondo M, Iseki C, Watanabe T; ‘Design of the Comprehensive
Health Care System for Chronic Kidney Disease (CKD) Based on the Individual Risk
Assessment by Specific Health Check’. Association of dipstick hematuria with all-causemortality in the general population: results from the specific health check and guidance
program in Japan. Nephrol Dial Transplant. 2018 1;33(5):825-832.
39. Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M,
Shibagaki Y, Moriyama T, Kondo M, Iseki C, Watanabe T; “Design of the Comprehensive
Health Care System for Chronic Kidney Disease (CKD) Based on the Individual Risk
Assessment by Specific Health Check”. Glucosuria and all-cause mortality among generalscreening participants. Clin Exp Nephrol. 2018 ;22(4):850-859.
40. Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M,
Shibagaki Y, Moriyama T, Kondo M, Iseki C, Watanabe T. Dipstick proteinuria and all-cause
mortality among the general population. Clin Exp Nephrol. 2018 Dec;22(6):1331-1340..
41. Ogata E, Asahi K, Yamaguchi S, Iseki K, Sato H, Moriyama T, Yamagata K, Tsuruya K,
Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, ShimabukuroM.

Low fasting plasma glucose level as a predictor of new-onset diabetes mellitus on alarge cohort from a Japanese general population. Sci Rep. 2018 Sep 17;8(1):13927. doi:
10.1038/s41598-018-31744-4.
42. Ishii A, Katsuura G, Imamaki H, Kimura H, Mori KP, Kuwabara T, Kasahara M, Yokoi H,
Ohinata K, Kawanishi T, Tsuchida J, Nakamoto Y, Nakao K, Yanagita M, Mukoyama M, Mori
K. Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associatedlipocalin in mice.

Sci Rep. 2017 Nov 14;7(1):15501. doi: 10.1038/s41598-017-15825-4.

43. Otaki Y, Watanabe T, Konta T, Watanabe M, Fujimoto S, Sato Y, Asahi K, Yamagata K,
Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T.
Effect of Hypertension on Aortic Artery Disease-Related Mortality - 3.8-Year Nationwide
Community-Based Prospective Cohort Study.

Circ J. 2018 Oct 25;82(11):2776-2782.

44. Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M,
Kasahara M, Shibagaki Y, Asahi K, Watanabe T.
Body shape index: Sex-specific differences in predictive power for all-cause mortality in theJapanese population. PLoS One. 2017 May 16;12(5):e0177779.
45. Kato Y, Mori K, Kasahara M, Osaki K, Ishii A, Mori KP, Toda N, Ohno S, Kuwabara T, Tokudome
T, Kishimoto I, Saleem MA, Matsusaka T, Nakao K, Mukoyama M, Yanagita M, Yokoi H.

Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury
evoked by aldosterone through p38 mitogen-activated protein kinase inhibition. Sci Rep. 2017
Apr 21;7:46624. doi: 10.1038/srep46624.
46. Iseki K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Konta T, Kasahara M, Shibagaki
Y, Yoshida H, Moriyama T, Kondo M, Iseki C, Watanabe T;“Design of the comprehensive health care system for chronic kidney disease (CKD) based on
the individual risk assessment by Specific Health Check”..
Mortality risk among screened subjects of the specific health check and guidance program inJapan 2008-2012.

Clin Exp Nephrol. 2017 Mar 3

47. Toda N, Mori K, Kasahara M, Ishii A, Koga K, Ohno S, Mori KP, Kato Y, Osaki K, Kuwabara T,
Kojima K, Taura D, Sone M, Matsusaka T, Nakao K, Mukoyama M, Yanagita M, Yokoi H. Crucial
Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of AntiGlomerular Basement Membrane Glomerulonephritis. Sci Rep. 2017 Feb 13;7:42114. doi:
10.1038/srep42114.
48. Ohno S, Yokoi H, Mori K, Kasahara M, Kuwahara K, Fujikura J, Naito M, Kuwabara T, Imamaki
H, Ishii A, Saleem MA, Numata T, Mori Y, Nakao K, Yanagita M, Mukoyama M. Ablation of the
N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control andreduced blood pressure. Sci Rep. 2016 Jun 7;6:27192. doi: 10.1038/srep27192.
49. Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno
S, Kuwahara K, Endo T, Nakao K, Yanagita M, Mukoyama M, Mori K.
Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy. J
Am Soc Nephrol. 2017 Jan;28(1):278-289. doi: 10.1681/ASN.2015101168. Epub 2016 Jul 6.
50. Fan Y, Futawaka K, Koyama R, Fukuda Y, Hayashi M, Imamoto M, Miyawaki T, Kasahara M,
Tagami T, Moriyama K.
Vitamin D3/VDR resists diet-induced obesity by modulating UCP3 expression in muscles. J
Biomed Sci. 2016 Jul 29;23(1):56.
51. Futawaka K, Tagami T, Fukuda Y, Koyama R, Nushida A, Nezu S, Yamamoto H, Imamoto M,
Kasahara M, Moriyama K.
Transcriptional activation of the wild-type and mutant vitamin D receptors by vitamin D3
analogs.

J Mol Endocrinol. 2016 Jul;57(1):23-32.

52. Futawaka K, Tagami T, Fukuda Y, Koyama R, Nushida A, Nezu S, Imamoto M, Kasahara M,
Moriyama K.
Growth hormone regulates the expression of UCP2 in myocytes.
Growth Horm IGF Res. 2016 Aug;29:57-62.
53. Moriyama K, Yamamoto H, Futawaka K, Atake A, Kasahara M, Tagami T.
Molecular characterization of human thyroid hormone receptor β isoform 4. Endocr Res.
2016;41(1):34-42.
54. Kamei K, Konta T, Hirayama A, Ichikawa K, Kubota I, Fujimoto S, Iseki K, Moriyama T, Yamagata
K, Tsuruya K, Narita I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, Watanabe T.
Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide
community-based cohort study. Clin Exp Nephrol. 2016
55. Kimura G, Kasahara M, Ueshima K, Tanaka S, Yasuno S, Fujimoto A, Sato T, Imamoto M,
Kosugi S, Nakao K.
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidneydisease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
Clin Exp Nephrol. 201656. Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno
S, Kuwahara K, Endo T, Nakao K, Yanagita M, Mukoyama M, Mori K.
Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic
Nephropathy.

J Am Soc Nephrol. 2016

57. Koshiba T, Nishiuchi T, Akaihata H, Haga N, Kojima Y, Kubo H, Kasahara M, Hayashi M.
Evaluating the Imbalance Between Increasing Hemodialysis Patients and Medical Staff
Shortage After the Great East Japan Earthquake: Report From a Hemodialysis Center Near
the Fukushima Nuclear Power Plants.
Ther Apher Dial. 2016 Apr;20(2):127-34. doi: 10.1111/1744-9987.12393. Epub 2016 Mar 2.
58. Li JE, Futawaka K, Yamamoto H, Kasahara M, Tagami T, Liu TH, Moriyama K.
Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.
Am J Chin Med. 2015;43(5):879-92.

59. Moriyama , Yamamoto , Futawaka , Atake , Kasahara, Tagami. Molecular c haracterization ofhuman thyroid hormone receptor β isoform 4.
Endocr Res. Oct 29:1-9. 2015
60. Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T, Mori KP, Kato Y, Kuwahara T, Satoh M,
Nakatani K, Saito Y, Tomosugi N, Sugawara A, Nakao K, Mukoyama M, Yanagita M, Mori K.
Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in
Maintenance Hemodialysis Patients. PLoS One. Jul 10;10 (7):e0132539. 2015
61. Uchida D, Kawarazaki H, Shibagaki Y, Yasuda T, Tominaga N, Watanabe T, Asahi K, Iseki K,
Iseki C, Tsuruya K, Yamagata K, Moriyama T, Narita I, Fujimoto S, Konta T, Kondo M, Kasahara
M, Kimura K.
Underestimating chronic kidney disease by urine dipstick without serum creatinine as ascreening tool in the general Japanese population.
Clin Exp Nephrol. 2015 Jun;19(3):474-80.
62. Koga K, Yokoi H, Mori K, Kasahara M, Kuwabara T, Imamaki H, Ishii A, Mori KP, Kato Y, Ohno
S, Toda N, Saleem MA, Sugawara A, Nakao K, Yanagita M, Mukoyama M. MicroRNA-26a
inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting
CTGF and is downregulated in diabetic nephropathy. Diabetologia. Sep;58 (9):2169-80. 2015
63. J. Kanda, K. Mori, H. Kawabata, T. Kuwabara, K.P. Mori, H. Imamaki, M. Kasahara, H. Yokoi, C.
Mizumoto, N.K. Thoennissen, H.P. Koeffler, J. Barasch, A. Takaori-Kondo, M. Mukoyama, K.
Nakao.
An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but fromneutrophils in normal and infected conditions.
Clin. Exp. Nephrol. 19(1):99-106. 2015.
64. M. Kasahara, T. Nakagawa, H. Yokoi, T. Kuwabara, S. Yasuno, K. Mori, M. Mukoyama, K.
Ueshima.
Do statins play a role in renoprotection?

Clin. Exp. Nephrol. 18(2): 282-285, 2014.
65. T. Kuwabara, K. Mori, M. Kasahara, H. Yokoi, H. Imamaki, A. Ishii, K. Koga, A. Sugawara, S.
Yasuno, K. Ueshima, T. Morikawa, Y. Konishi, M. Imanishi, A. Nishiyama, K. Nakao, M. Mukoyama.
Predictive significance of kidney myeloid-related protein 8 expression in patients withobesity- or type 2 diabetes-associated kidney diseases.

PLoS One. 9(2): e88942, 2014.
66. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, K. Nakao. Macrophage-mediatedglucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic
nephropathy.

Clin. Exp. Nephrol. Aug;18(4):584-92. 2014
67. K. Ueshima, M. Kasahara, D. Koya, T. Babazono, T. Sato, M. Imamoto, S. Yasuno, A. Fujimoto,S. Tanaka, G. Kimura, K. Nakao.
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidneydisease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with
Atorvastatin (ASUCA) trial.

Clin. Exp. Nephrol. 17(2): 211-217, 2013.
68. H. Yokoi, M. Kasahara, K. Mori, T. Kuwabara, N. Toda, R. Yamada, S. Namoto, T. Yamamoto, N.
Seki, N. Souma, T. Yamaguchi, A. Sugawara, M. Mukoyama, K. Nakao.
Peritoneal Fibrosis and High Transport Are Induced in Mildly Pre-injured Peritoneum by 3,4Dideoxyglucosone-3-ene in Mice.

Perit. Dial. Int. 33(2): 143-154, 2013.
69. H. Yokoi, M. Kasahara, K. Mori, Y. Ogawa, T. Kuwabara, H. Imamaki, Kawanishi T, K. Koga, A.
Ishii, Y. Kato, K.P. Mori, N. Toda, S. Ohno, H. Muramatsu, T. Muramatsu, A. Sugawara, M.
Mukoyama, K. Nakao.
Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal
fibrosis.

Kidney Int. 81(2): 160-169, 2012.
70. Y. Ogawa, M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, Y. Kato, T. Kuwabara, H. Imamaki, T.
Kawanishi, K. Koga, A. Ishii, T. Tokudome, I. Kishimoto, A. Sugawara, K. Nakao.
Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosteroneinduced glomerular injury.

J. Am. Soc. Nephrol. 23(7): 1198-1209, 2012.
71. Y.M. Nakao, S. Teramukai, S. Tanaka, S. Yasuno, A. Fujimoto, M. Kasahara, K. Ueshima, K.
Nakao, S. Hinotsu, K. Nakao, K. Kawakami.

Effects of renin-angiotensin system blockades on cardiovascular outcomes in patients withdiabetes mellitus: A systematic review and meta-analysis.

Diabetes Res. Clin. Pract. 96(1): 68-75, 2012.
72. Y.M. Nakao, T. Miyawaki, S. Yasuno, K. Nakao, S. Tanaka, M. Ida, M. Hirata, M. Kasahara, K.
Hosoda, K. Ueshima, K. Nakao.
Intra-abdominal fat area is a predictor for new onset of individual components of metabolic
syndrome: Metabolic syndrome and abdominal obesity (MERLOT study).

Proc. Japan Acad. Ser. B: Phys. Biol. Sci. 88(8): 454-461, 2012.
73. K. Minakata, K. Bando, S. Takanashi, H. Konishi, Y. Miyamoto, K. Ueshima, T. Sato, Y. Ueda, Y.
Okita, I. Masuda, H. Okabayashi, H. Yaku, S. Yasuno, H. Muranaka, M. Kasahara, S. Miyata, Y.
Okamura, M. Nasu, K. Tanemoto, K. Arinaga, Y. Hisashi, R. Sakata.
Impact of diabetes mellitus on outcomes in Japanese patients undergoing coronary artery
bypass grafting.

Journal of cardiology 59(3): 275-284, 2012.
74. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, Y. Ogawa, H. Imamaki, T.
Kawanishi, A. Ishii, K. Koga, K.P. Mori, Y. Kato, A. Sugawara, K. Nakao.
Exacerbation of diabetic nephropathy by Hyperlipidaemia is mediated by Toll-like receptor 4
in mice.

Diabetologia 55(8): 2256-2266, 2012.
75. Yokoi H, Kasahara M, Mukoyama M, Mori K, Kuwahara K, Fujikura J, Arai Y, Saito Y, Ogawa Y,
Kuwabara T, Sugawara A, Nakao K. Podocyte-specific expression of tamoxifen-inducible Cre
recombinase in mine. Nephrol Dial Transplant.2010; 25(7): 2120-2124.
76. Tanaka M, Suganami T, Sugita S, Shimoda Y, Kasahara M, Aoe S, Takeya M, Takeda S, Kamei
Y, Ogawa Y. Role of Central Leptin Signaling in Renal Macrophage Infiltration. Endocr J. 2010;
57(1): 61-72.
77. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y,
Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K.
Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal
tubules, and distal nephrons. Kidney Int. 2009; 75(3): 285-294.

78. Kasahara M, Mori K, Satoh N, Kuwabara T, Yokoi H, Shimatsu A, Sugawara A, Mukoyama M,
Nakao K. Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin byangiotensin receptor blockers in hypertensive patients. Nephrol Dial Transplant.2009; 24(8):2608-2609.
79. Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, Sawai K, Yoshioka T, Saito Y, Ogawa
Y, Kuwabara T, Sugawara A, Nakao K. Overexpression of connective tissue growth factor
worsens diabetic nephropathy in mice. Kidney Int. 2008; 73(4): 446-455.
80. Nagae T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Suganami T, Sawai K, Yoshioka T,
Koshikawa M, Saito Y, Ogawa Y, Kuwabara T, Tanaka I, Sugawara A, Kuwahara T, Nakao K.
Adrenomedullin inhibits connective tissue growth factor expression, extracellular signalregulated kinase activation and renal fibrosis. Kidney Int. 2008; 74(1): 70-80.
81. Sawai K, Mukoyama M, Mori K, Kasahara M, Koshikawa M, Yokoi H, Yoshioka T, Ogawa Y,
Sugawara A, Nishiyama H, Yamada S, Kuwahara T, Saleem MA, Shiota K, Ogawa O, Miyazato
M, Kangawa K, Nakao K. Expression of CCN1 (CYR61) in developing, normal, and diseased
human kidney. Am J Physiol Renal Physiol.2007; 293(4): F1363-1372.
82. Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya
R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Sato M, Yorioka N, Kawaguchi
Y. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal
dialysis. Am J Nephrol. 2007; 27 (4): 409-415.
83. Makino H, Mukoyama M, Mori K, Suganami T, Kasahara M, Yahata K, Nagae T, Yokoi H, Sawai
K, Ogawa Y, Suga S, Yoshimasa Y, Sugawara A, Tanaka I, Nakao K. Transgenic overexpressionof brain natriuretic peptide prevents the progression of diabetic nephropathy in mice.
Diabetologia. 2006; 49(10): 2514-2524.
84. Nakamoto H, Babazono T, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya
R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Yorioka N, Sato M, Yamabe K,
Kawaguchi Y. Successful use of icodextrin in elderly patients on continuous ambulatory
peritoneal dialysis. Adv Perit Dial. 2005; 21: 168-174.
85. Goto M, Mukoyama M, Sugawara A, Suganami T, Kasahara M, Yahata K, Makino H, Suga S,
Tanaka I, Nakao K. Expression and role of angiotensin II type 2 receptor in the kidney andmesangial cells of spontaneously hypertensive rats. Hypertens Res.2002; 25(1): 125-133.
86. Suganami T, Tanaka I, Mukoyama M, Kotani M, Muro S, Mori K, Goto M, Ishibashi R, Kasahara
M, Yahata K, Makino H, Sugawara A, Nakao K. Altered growth response to prostaglandin E2
and its receptor signaling in mesangial cells from stroke-prone spontaneously hypertensive
rats. J Hypertens.2001; 19(6): 1095-1103.
87. Ishii A, Katsuura G, Imamaki H, Kimura H, Mori KP, Kuwabara T, Kasahara M, Yokoi H, Ohinata
K, Kawanishi T, Tsuchida J, Nakamoto Y, Nakao K, Yanagita M, Mukoyama M, Mori K. Obesitypromoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice.
Sci Rep. 2017; 7(1): 15501.
88. Nagae T, Mukoyama M, Sugawara A, Mori K, Yahata K, Kasahara M, Suganami T, Makino H,
Fujinaga Y, Yoshioka T, Tanaka I, Nakao K. Rat receptor-activity-modifying proteins (RAMPs)
for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy.
Biochem Biophys Res Commun. 2000; 270(1): 89-93.
89. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R,
Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M, Nakao K. Cardiac
fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA. 2000; 97(8): 42394244.
90. Kasahara M, Mukoyama M, Sugawara A, Makino H, Suganami T, Ogawa Y, Nakagawa M, Yahata
K, Goto M, Ishibashi R, Tamura N, Tanaka I, Nakao K. Ameliorated glomerular injury in miceoverexpressing brain natriuretic peptide with renal ablation. J Am Soc Nephrol. 2000; 11(9):1691-1701.
91. Goto M, Mukoyama M, Suga S, Matsumoto T, Nakagawa M, Ishibashi R, Kasahara M, Sugawara
A, Tanaka I, Nakao K. Growth-Dependent Induction of Angiotensin II Type 2 Receptor in Rat
Mesangial Cells. Hypertension.1997; 30(3): 358-362.